PulseMedica is an Edmonton-based startup developing a platform that is intended to be the first safe, effective, and non-invasive system to screen and treat vitreoretinal disease, starting with symptomatic vitreous opacities (eye floaters). This seminar will focus on how PulseMedica is applying machine learning to detect, track and treat eye floaters.